Completed OBSERVATIONAL NCT01273077

Evaluation of Universal Rotavirus Vaccination Program

Sponsor: Dalhousie University

Updated 6 times since 2017 Last updated: Jan 19, 2022 Started: Dec 31, 2010 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Gastrointestinal Diseases and is currently completed. Dalhousie University leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2022 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Mar 2022 [monthly]

Unknown Status
Apr 2018 — Jan 2021 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dalhousie University
GlaxoSmithKline
Horizon Health Care New Brunswick
IWK Health Centre
Nova Scotia Health Authority
University of Prince Edward Island

Data source: Dalhousie University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Halifax, Canada